Skip to main content
PMC home page
Nutrition Journal logoLink to Nutrition Journal
. 2011 Nov 2;10:121. doi: 10.1186/1475-2891-10-121

Dietary fat intake and quality of life: the SUN project

Cristina Ruano 1, Patricia Henriquez 1, Maira Bes-Rastrollo 2, Miguel Ruiz-Canela 2, Cristina López del Burgo 2, Almudena Sánchez-Villegas 1,2,✉
PMCID: PMC3215177  PMID: 22047452

Abstract

Background

Few studies have related nutritional factors with quality of life in healthy populations. The purpose of the study was to assess whether dietary fat intake is associated to mental and physical quality of life.

Methods

This analysis included 8,430 participants from the SUN (Seguimiento Universidad de Navarra) Project. The intake of saturated fatty acids (SFA), polyunsaturated fatty acids (PUFA), trans unsaturated fatty acids (TFA), and monounsaturated fatty acids (MUFA) was assessed through a 136-item food frequency questionnaire at baseline. Quality of life was measured with the SF-36 Health Survey after 4 years of follow-up. Generalized Linear Models were fitted to assess the regression coefficients (b) and their 95% confidence intervals (95% CI) for the 8 domains of the SF-36 according to successive quintiles of each kind of fatty acids intake.

Results

The multivariate-adjusted models revealed a significant inverse association for SFA intake (in quintiles) and two of the physical domains (physical functioning and general health). E.g. for general health domain: (highest quintile of intake (Q5) vs. lowest quintile (Q1), b = -1.6; 95% CI = -3.1, -0.1. General health also showed a dose-response relationship (p for trend < 0.05). For TFA intake (in quintiles), a significant inverse association was found for most of the mental domains (vitality, social functioning and role emotional). E.g. for vitality domain (Q5) vs. (Q1), b = -2.0, 95% CI = -3.4 to -0.6. We also found an inverse association between TFA intake and the bodily pain domain: (Q5 vs. Q1), b = -2.6; 95% CI = -4.4 to -0.8, with a statistically significant dose-response relationship (p for trend < 0.05). Except for TFA intake and the mental domains, the rest of the associations were attenuated when we repeated the analysis adjusting for adherence to the Mediterranean diet.

Conclusions

A detrimental relationship between TFA intake at baseline and most of the SF-36 mental domains measured 4 years later were found, whereas weak inverse associations were found for SFA intake and some physical domains.

Keywords: Dynamic cohort, Fatty acids intake, SF-36 Health Survey, Mental quality of life, Physical quality of life

Background

Quality of life is a broad concept that relates to all aspects of human life. Quality of life questionnaires have become an efficient way of gathering data about people functioning and well being. Also health status measures have been shown to be a powerful predictor for chronic diseases and mortality over the long term in clinical practice [1,2]. Moreover, population ageing has fostered the general concern for obtaining a better health-related quality of life [3].

Epidemiological studies have shown the influence of different factors such as smoking, obesity, or crash injuries on quality of life [4-7]. However, few longitudinal studies have analyzed the influence of diet on the quality of life of healthy populations [8-10]. Several studies have found that the adherence to a Mediterranean dietary pattern rich in fruits and vegetables, legumes, fish and olive oil, was associated with higher scoring for self-perceived health [11,12]. On the other hand, some studies have shown the detrimental effects on health of a "Western-type" dietary pattern rich in processed and red meats, refined grains and commercial baked goods [13-16]. The Western dietary pattern is the common diet in Northern Europe and the USA. In recent years, however, southern European countries, which used to eat a traditional Mediterranean diet, have also been adopting a more Western-style diet. Beyond the health effects of an overall Western dietary pattern, little is known about the health effects of the diet's specific elements, such as major fat sources, on quality of life.

There has been a dramatic change in the sources of fat intake in the general population. This change mainly consists in replacing polyunsaturated (PUFA) or monounsaturated fatty acids (MUFA) with saturated fats (SFA) and trans unsaturated fats (TFA). Usually, PUFA [17] and olive oil (OO) [18-20] have been considered as healthy lipids because they reduce the incidence of cardiovascular disease (CVD). In contrast, SFA and especially TFA are known risk factors for CVD [21]. There are some reasons to expect that CVD share some common determinants, [22] endothelial dysfunction and high levels of pro-inflammatory cytokines, with other pathologies like obesity, insulin resistance and neuropsychological disorders. All of these physiological processes may have also an influence on physical and mental quality of life in healthy population.

From a public health perspective, it is necessary to identify the nutritional factors that could increase or decrease the quality of life and health status of the population. The aim of this study was to assess the association between dietary fat intake and self-perceived health-related mental and physical quality of life in a Mediterranean cohort, the SUN Project.

Methods

Study population

The "Seguimiento Universidad de Navarra'' (SUN) Project is an ongoing, multipurpose, dynamic cohort of university graduates conducted in Spain and started in December 1999. As a dynamic cohort, the recruitment of the participants is permanently open. The study methods and the cohort profile have been published in detail elsewhere [23,24].

Information on exposures and outcomes is gathered by postal mail or web-based questionnaires collected biannually. Participants answer a baseline questionnaire assessing multiple exposures such as nutritional habits, physical exercise, medical conditions and other risk factors. Every two years they answer the follow-up questionnaires assessing changes in exposures and new events of interest.

Up to November 2010, 15,089 participants had responded to the baseline and to the 4-year follow-up questionnaire. As the recruitment is permanently open, with approximately 2,000 new participants each year, only those entering the cohort before 2005 could be followed-up for 4 years. The overall retention rate is 92%. From those participants who were assessed after 4-year (15,089), we excluded those who reported extremely low or high values for total energy intake (less than 800 Kcal/day or more than 4,000 Kcal/day in men and less than 500 Kcal or more than 3,500 Kcal/day in women (n = 1,489), those who reported dyslipidemia and cardiovascular disease at baseline (n = 2,924), and those without or with incorrect data regarding quality of life (n = 2,246). Finally, 8,430 participants were included in this analysis.

The study was approved by the Human Research Ethical Committee at the University of Navarra. Voluntary completion of the first questionnaire was considered to imply informed consent. Our Institutional Review Board specifically approved this consent process.

Exposure assessment

Dietary intake was assessed using a semi-quantitative food frequency questionnaire (136 food items) included at baseline [25]. Validity and reproducibility of this questionnaire has recently been re-evaluated [26]. It showed reasonably good validity for assessing fat intake (energy-adjusted intraclass correlation coefficients for different types of fats versus four 3-day food records ranged from 0.49 to 0.75) [27]. Nutrient intakes of 136 food items were calculated as frequency multiplied by nutrient composition of specified portion size for each food item, using an ad hoc computer program developed for this purpose. A trained dietician updated the nutrient data bank using the latest available information from the food composition table for Spain [28,29].

Baseline intake of every dietary fat: MUFA, n-3 PUFAs, n-6 PUFAs, SFA and TFA were analyzed as quantitative variables (grams per day) and categorized into quintiles. We also analyzed as quantitative variables several culinary fats like seed oil, butter, margarine, and olive oil and we categorized them into quintiles. Adjustments were made for total energy intake by using the residuals method proposed by Willet [30]. The ratio n-3/n-6 was also computed [31].

Outcome assessment

Quality of life was assessed after a 4-year follow-up with the validated Spanish version of the SF-36 Health Survey. The SF-36 is a general health scale widely used and thoroughly validated [32]. The questionnaire contains 36 items that measure eight multi-item parameters of health status: physical functioning, role limitations due to physical health problems (role-physical), bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems (role emotional) and mental health. Domains 1 to 4 of the questionnaire deal with physical aspects, while domains 5 to 8 measure psychological features. For each parameter, scores were coded, summed and transformed to a scale from 0 (the worst possible condition) to 100 (the best possible condition). For example, for bodily pain a score of 100 means a complete tolerance to pain.

Covariate assessment

The baseline assessment also gathered information on socio-demographic variables (e.g. sex, age, marital status and employment status), anthropometric variables (e.g., weight and height), lifestyle and health-related habits (e.g., smoking status), and medical history (e.g., chronic diseases) [24]. Self-reported body mass index (BMI) was calculated as weight (in kilograms) divided by the square of height (in meters). Self-reported anthropometrics were previously been validated in a subsample of the cohort [33].

At baseline, participants also completed a validated physical activity questionnaire that collects information about 17 activities [34]. Leisure-time activities were computed by assigning an activity metabolic equivalent (MET) score to each activity, multiplied by the time spent in each activity and summing up all activities [35].

Information about alcohol intake was obtained through the semi-quantitative food frequency questionnaire included in the baseline questionnaire.

Adherence to the Mediterranean diet was assessed combining 8 items (fruits and nuts, vegetables, fish, legumes, cereals, meat and meat products, dairy and alcohol intake) [36]. To avoid overlapping with our main exposure, we excluded the ratio MUFA/SFA item from this score (the actual range in our study was from 0 to 8).

Statistics

Generalized Linear Models were used to assess the relationship between quintiles of total fat and specific dietary fatty acids intake and each domain of the SF- 36 Health Survey, using always the lowest quintile as the reference. Regression coefficients (b) and their 95% confidence intervals (95% CI) were calculated. Tests of linear trend across successive quintiles were conducted by assigning the medians to each quintile and treating this consumption as a continuous variable.

Age (years, continuous), sex, BMI at baseline (Kg/m2), total energy intake (Kcal/day, continuous), physical activity during leisure time (METS- h/week, continuous) and smoking (never, ex smokers and current smokers) were considered as potential confounders in all the models. To further reduce potential confounding, all others fatty acids not considered as exposure variable were also include as covariates in the models. Finally, additional adjustments were made to take into account Mediterranean diet-pattern adherence.

The SPSS software package for Windows version 18.0 (SPSS Inc., Chicago, IL) was used for statistical analyses.

Results

The main characteristics of the study population according to extreme quintiles of SFA, TFA, MUFA and PUFA intake are shown in Table 1. Younger participants, men and current smokers were more likely to belong to the highest level of SFA and TFA intake (Q5). Participants in Q5 were also less active compared to those in the lowest quintile (Q1). The adherence to the Mediterranean diet score decreased across quintiles of SFA, TFA, MUFA and PUFA intake. This decrease in the score is lower for quintiles of MUFA and PUFA intake.

Table 1.

Baseline characteristics* according to extreme quintiles of specific types of fat intake in the SUN project.

Characteristic Saturated fat Trans unsaturated fat MUFA fat PUFA fat
Q1 Q5 Q1 Q5 Q1 Q5 Q1 Q5
Sex (% men) 37.7 41.1 34.5 43.8 42.9 28.8 36.8 38.8
Age at baseline (y) 39.4 (11.9) 34.6 (9.9) 38.9 (11.6) 35.1 (10.2) 38.4 (12.0) 36.2 (10.6) 37.8 (11.2) 35.3 (10.9)
BMI (kg/m2) 23.4 (3.3) 23.0 (3.3) 23.2 (3.3) 23.0 (3.3) 23.3 (3.2) 23.0 (3.3) 23.1 (3.3) 22.9 (3.3)
Smoking:
 Ex smoker (%) 30.4 22.7 30.6 22.0 26.9 29.2 29.1 26.0
 Current (%) 19.9 25.3 20.3 23.5 19.7 26.0 21.6 23.2
Leisure time physical activity (Mets-h/wk) 23.6 (25.9) 19.3 (24.1) 23.6 (25.8) 19.1 (21.8) 23.4 (26.4) 19.0 (21.7) 23.2 (27.1) 18.8 (21.3)
Total energy intake (Kcal/d) 2537 (581) 2495 (616) 2616 (551) 2508 (594) 2534 (577) 2503 (610) 2617 (517) 2519 (616)
Mediterranean Dietary Score (0-8) 4.9 (1.4) 2.8 (1.4) 4.8 (1.4) 2.9 (1.5) 4.5 (1.5) 3.4 (1.6) 4.3 (1.6) 3.8 (1.6)
Total fat intake (g/d)* 80.4 (15.9) 113.7 (13.7) 87.8 (19.3) 107.4 (15.1) 77.0 (12.6) 118.5 (12.9) 84.1 (17.4) 108.7 (16.1)
Saturated fat intake (g/d)* 22.8 (4.2) 45.5 (6.4) 25.8 (6.8) 42.0 (8.4) 26.4 (6.3) 39.2 (9.3) 31.0 (9.8) 34.8 (8.4)
Monounsaturated fat intake (g/d)* 34.5 (9.4) 48.4 (8.5) 38.5 (11.6) 45.0 (8.6) 29.6 (4.6) 56.0 (7.3) 35.2 (8.7) 46.0 (10.2)
Polyunsaturated fat intake (g/d)* 12.9 (5.1) 14.6 (4.3) 13.5 (5.3) 14.3 (4.1) 11.6 (4.2) 16.2 (4.9) 9.0 (1.7) 20.5 (4.0)
Trans unsaturated fat intake (g/d)* 0.6 (0.3) 1.5 (0.6) 0.4 (0.2) 1.7 (0.4) 0.8 (0.4) 1.2 (0.6) 0.9 (0.6) 1.0 (0.5)
Open in a new tab

*Continuous variables are expressed as the mean and (standard deviation). Categorical variables are expressed as percentages.

MUFA: Monounsaturated fatty acid. PUFA: Polyunsaturated fatty acid. Q1: First quintile (lowest intake). Q5: Fifth quintile (highest intake)

Table 2 shows the multivariate regression coefficients (b) and their 95% CI for the mental domains of the SF-36 according to baseline SFA and TFA intake (in quintiles). The multivariate-adjusted model revealed a significant inverse association between TFA intake and most of the mental domains (vitality, social functioning and role emotional). For example: b = -2.0, 95% CI = -3.4 to -0.6 (Q5 vs. Q1), for the vitality domain. Moreover a statistically significant dose-response relationship (p for trend < 0.05) was found for each domain except for mental health. No association was found for SFA intake and the mental domains.

Table 2.

Regression coefficients (b) and 95% Confidence Intervals (CI) for the association between baseline saturated (SFA) and trans unsaturated (TFA) fatty acid intake and the SF-36 mental domains after 4-y follow-up.

Baseline saturated fatty acid intake
SF-36 mental scores after 4 years of follow-up Q1 Q2 Q3 Q4 Q5 p linear trend
Energy-adjusted SFA intake (g/day) (median) 22.8 29.7 33.5 37.3 45.5
Vitality
Multivariate adjusted model (1) 0 (ref.) -0.7 (-1.8, 0.5) -0.2 (-1.4, 1.0) -0.2 (-1.5, 1.1) -1.4 (-2.9, 0.1) 0.166
Additionally adjusted for MD (2) 0 (ref.) -0.4 (-1.6, 0.7) 0.2 (-1.0, 1.4) 0.2 (-0.9, 1.7) -0.7 (-2.2, 0.9) 0.682
Social functioning
Multivariate adjusted model (1) 0 (ref.) 0.3 (-0.7, 1.3) 1.0 (-0.02, 2.1) 0.6 (-0.5, 1.6) -0.3 (-1.7, 1.0) 0.779
Additionally adjusted for MD (2) 0 (ref.) 0.3 (-0.7, 1.3) 1.1 (-0.09, 2.2) 0.7 (-0.5, 1.9) -0.6 (-1.6, 0.5) 0.924
Role emotional
Multivariate adjusted model (1) 0 (ref.) 1.8 (-0.2, 3.8) 2.3 (0.2, 4.5) 3.0 (0.7, 5.2) 2.0 (-0.7, 4.7) 0.099
Additionally adjusted for MD (2) 0 (ref.) 1.9 (-0.2, 3.8) 2.3 (0.1, 4.4) 3.0 (0.7, 5.3) 2.1 (-0.6, 4.9) 0.099
Mental health
Multivariate adjusted model (1) 0 (ref.) 0.3 (-0.7,1.2) 0.7 (-0.3, 1.6) 0.5 (-0.4, 1.5) -0.7 (-1.9, 0.6) 0.520
Additionally adjusted for MD (2) 0 (ref.) 0.3 (-0.7, 1.2) 0.6 (-0.4, 1.6) 0.5 (-0.5, 1.6) -0.7 (-1.9, 0.7) 0.530
Baseline trans unsaturated fatty acid intake
Energy-adjusted TFA intake (g/day) (median) 0.4 0.8 1.0 1.2 1.7
Vitality
Multivariate adjusted model (1) 0 (ref.) -1.3 (-2.4, -0.2) -0.6 (-1.8, 0.5) -0.2 (-1.8, 0.6) -2.0 (-3.4, -0.6) 0.056
Additionally adjusted for MD (2) 0 (ref.) -1.2 (-2.3, -0.1) -0.4 (-1.6, 0.7) 0.1 (-1.1, 1.3) -1.6 (-3.0, -0.2) 0.162
Social functioning
Multivariate adjusted model (1) 0 (ref.) -0.4 (-1.4, 0.6) -0.2 (-1.3, 0.8) -0.2 (-1.3, 0.8) -1.7 (-2.9, -0.5) 0.013
Additionally adjusted for MD (2) 0 (ref.) -0.5 (-1.5, 0.6) -0.2 (-1.3, 0.8) -0.2 (-1.3, 0.8) -1.7 (-2.9, -0.4) 0.017
Role emotional
Multivariate adjusted model (1) 0 (ref.) 0.2 (-1.8, 2.2) 0.3 (-1.8, 2.4) 0.4 (-1.8, 2.4) -3.5 (-6.0, -1.0) 0.006
Additionally adjusted for MD (2) 0 (ref.) 0.1 (-1.9, 2.1) 0.2 (-1.9, 2.3) 0.4 (-1.8, 2.6) -3.5 (-6.0, -1.0) 0.007
Mental health
Multivariate adjusted model (1) 0 (ref.) -0.3 (-1.3, 0.6) -0.1 (-1.1, 1.0) 1.0 (-0.1, 2.1) -0.2 (-1.4, 1.1) 0.646
Additionally adjusted for MD (2) 0 (ref.) -0.3 (-1.3, 0.7) -0.1 (-1.2, 0.9) 0.9 (-0.2, 2.0) -0.2 (-1.4, 0.7) 0.634
Open in a new tab

The SUN cohort 1999-2010.

Vitality: vitality and energy feelings against tiredness or exhaustion

Social Functioning: grade in which mental health problems can interfere with habitual social life

Role Emotional: grade in which mental health problems can interfere with work activity or with other daily activities

Mental Health: general mental health including depression, anxiety, emotional and behaviour control and general positive effect

(1): Model adjusted for age, sex, smoking (non smoker, current, ex-smoker and missing value), leisure time physical activity (in quintiles of METs-h/wk score), total energy intake (Kcal/day), and baseline BMI (Kg/m2), MUFA, PUFA and, additionally, SFA (TFA intake) or TFA (SFA model).

(2): Model 1 additionally adjusted for adherence to the Mediterranean Diet score (0-8) (excluding SFA/MUFA ratio).

Multivariate regression coefficients and their 95% CI for the physical domains of the SF-36 according to baseline SFA and TFA intake (in quintiles) are shown in Table 3.

Table 3.

Regression coefficients (b) and 95% Confidence Intervals (CI) for the association between baseline saturated (SFA) and trans unsaturated fatty (TFA) acid intake and the SF-36 physical domains after 4-y follow-up.

Baseline saturated fatty acid intake
SF-36 physical scores after 4 years of follow-up Q1 Q2 Q3 Q4 Q5 p linear trend
Energy-adjusted SFA intake (g/day) (median) 22.8 29.7 33.5 37.3 45.5
Physical functioning
Multivariate adjusted model (1) 0 (ref.) 0.2 (-0.5, 0.8) -0.04(-0.7, 0.6) -0.6 (-1.3, 0.1) -1.0 (-1.9, -0.2) 0.520
Additionally adjusted for MD (2) 0 (ref.) 0.3 (-0.4, 0.9) 0.1 (-0.5, 0.8) -0.3 (-1.0, 0.4) -0.7 (-1.5, 0.2) 0.068
Role physical
Multivariate adjusted model (1) 0 (ref.) 0.1 (-1.8, 2.0) 0.8 (-1.2, 2.8) 1.1 (-1.0, 3.2) -1.7 (-4.2, 0.9) 0.384
Additionally adjusted for MD (2) 0 (ref.) 0.3 (-1.5, 2.2) 1.2 (-0.8, 3.2) 1.6 (-0.6, 3.7) -1.1 (-3.7, 1.5) 0.676
Bodily pain
Multivariate adjusted model (1) 0 (ref.) 0.1 (-1.3, 1.6) 0.4 (-1.1, 2.1) 0.4 (-1.2, 2.0) -0.6 (-2.5, 1.3) 0.664
Additionally adjusted for MD (2) 0 (ref.) 0.3 (-1.2, 1.7) 0.7 (-0.9, 2.3) 0.9 (-0.8, 2.5) 0.03 (-2.1, 2.0) 0.831
General health
Multivariate adjusted model (1) 0 (ref.) 0.2 (-0.9, 1.3) -0.1 (-1.2, 1.1) -0.5 (-1.8, 0.8) -1.6 (-3.1, -0.1) 0.027
Additionally adjusted for MD (2) 0 (ref.) 0.3 (-0.8, 1.5) 0.3 (-1.0, 1.5) -0.02 (-1.3, 1.3) -1.0 (-2.5, 0.6) 0.206
Baseline transunsaturated fatty acid intake
Energy-adjusted TFA intake (g/day) (median) 0.4 0.8 1.0 1.2 1.7
Physical functioning
Multivariate adjusted model (1) 0 (ref.) -0.4 (-1.0, 0.2) 0.2 (-0.5, 0.8) -0.1 (-0.8, 0.6) -0.8 (-1.5, 0.02) 0.111
Additionally adjusted for MD (2) 0 (ref.) -0.4 (-1.0, 0.2) 0.2 (-0.4, 0.9) -0.02 (-0.7, 0.7) -0.6 (-1.4, 0.2) 0.289
Role physical
Multivariate adjusted model (1) 0 (ref.) -0.8 (-2.6, 1.1) 0.09 (-1.9, 2.0) -1.0 (-3.0, 1.1) -2.3 (-4.6, 0.04) 0.050
Additionally adjusted for MD (2) 0 (ref.) -0.7,(-2.5, 1.2) 0.3 (-1.7, 2.2) -0.8 (-2.8, 1.3) -2.0 (-4.4, 0.3) 0.085
Bodily pain
Multivariate adjusted model (1) 0 (ref.) -1.9 (-3.4, -0.5) -1.2 (-2.7, 0.3) -1.8 (-3.4, -0.2) -2.6 (-4.4, -0.8) 0.017
Additionally adjusted for MD (2) 0 (ref.) -1.9 (-3.4, -0.5) -1.1 (-2.6, 0.4) -1.6 (-3.2, -0.1) -2.3 (-4.1, -0.5) 0.042
General health
Multivariate adjusted model (1) 0 (ref.) -0.03 (-1.2, 1.1) 1.3 (0.1, 2.5) 0.6 (-0.6, 1.9) -1.1 (-2.5, 0.3) 0.161
Additionally adjusted for MD (2) 0 (ref.) 0.02 (-1.1, 1.1) 1.5 (0.3, 2.7) 0.9 (-0.4, 2.1) -0.8 (-2.2, 0.6) 0.367
Open in a new tab

The SUN cohort 1999-2010.

Physical Functioning: grade in which health problems can interfere with physical activities such as walking, self-care or weight lifting

Role Physical: grade in which physical health problems can interfere with work activity or with other daily activities

Bodily Pain: pain intensity and its effect on work inside and outside home

General Health: personal belief regarding current health and future perspectives regarding health

(1): Model adjusted for age, sex, smoking (non smoker, current, ex-smoker and missing value), leisure time physical activity (in quintiles of METs-h/wk score), total energy intake (Kcal/day), and baseline BMI (Kg/m2), MUFA, PUFA and, additionally, SFA (TFA intake) or TFA (SFA model).

(2): Model 1 additionally adjusted for adherence to the Mediterranean Diet score (0-8) (excluding SFA/MUFA ratio).

For SFA intake, a significant inverse association was found for physical functioning, and general health domains. For the general health domain: (Q5 vs. Q1), b = -1.6; 95% CI = -3.1 to -0.1. General health also showed a statistically significant dose -response relationship (p for trend < 0.05). For TFA, an inverse association was found for bodily pain: (Q5 vs. Q1), b = -2.6; 95% CI = -4.4 to -0.8 with a dose-response relationship (p for trend < 0.05).

When we repeated the analysis additionally adjusting for the adherence to a Mediterranean diet score, the association remained significant for TFA intake and the mental domains and bodily pain.

No association was observed between n-3 PUFAs, n-6 PUFAs, MUFA or the ratio n-3 vs. n-6 intake and the SF-36 domains. Neither was found for seed oils, butter, margarine or olive oil (data not shown).

Discussion

The present study showed a harmful association between the highest intake of TFA and several SF-36 domains. The association remained significant for the mental domains (except for mental health), and bodily pain after controlling for potential cofounders including the adherence to the Mediterranean diet. An inverse association for SFA intake and some of the physical domains was also found, although after adjusting for the adherence to the Mediterranean diet score this relationship was not statistically significant.

These associations could mean that the physiological changes that occur when this kind of fatty acid is consumed could influence mostly the mental quality of life and therefore the self perception of "well being". So, the participants with the highest intake would perceive themselves more tire and worn out, with social and role disability due to emotional problems, and with severe limiting pain than the participants with the lowest TFA intake. Although these are perceived health measures rather than biological measures, self-related heath status has been shown to be a powerful predictor of mortality at long term [2].

On the other hand, for the mental quality of life domains, the magnitude of the differences between the lowest and highest quintile of TFA intake were about 1.5-3 points. There is a debate on how to define meaningful differences on the SF-36 scores in a clinical setting. Changes in 3-, 5-, and 10- points have been suggested as being clinically significant for clinical populations [37]. Given the characteristics of our cohort that did not include patients, but healthy and relatively young adults, the practical significance of these differences could be even higher. Although few studies have examined this issue directly, several investigators have raised the question of whether individuals with more severe impairments in HRQOL require a greater change to be considered meaningful than those with less severe impairments [38].

Fatty acids of trans configuration come from two main different sources: the major source is derived from industrially produced partially hydrogenated fat used in margarines, commercial cooking, and manufacturing processes (60% of the fats), and smaller amounts are naturally present in dairy and meat products from ruminants (6% of the fats) [39]. Based on the evidence to date, TFA intake, particularly the industrial trans-18:2 isomer, is associated with substantial risk of coronary heart disease (CHD) [40-43]. The adverse effects of TFA on CVD are thought to be mediated by increases in plasma concentrations of LDL-cholesterol, reductions in HDL-cholesterol, pro-inflammatory changes, endothelial dysfunction, and possibly by insulin resistance and displacement of essential fatty acids from membranes [44,45].

The relation of TFA intake to other disease outcomes has been examined less extensively than for CHD. However, emerging evidence suggests that TFA acid intake may influence additional non -lipid related pathways and outcomes. These include effects on systemic inflammation, endothelial dysfunction, visceral adiposity, insulin resistance, and arrhythmic risk [46]. Moreover, TFA intake has been linked to accelerated cognitive decline in older adults [47], and higher risk of Alzheimer [48], and depression [49]. The harmful effect of TFA intake in these neuropsychological disorders supports our results which suggest that TFA intake specially affects mental quality of life. A possible explanation for our finding is that TFA promote endothelial dysfunction and increase the production of pro-inflammatory cytokines that may interfere with neurotransmitter metabolism and inhibit Brain-derived neurotrophic factor (BDNF) expression among other physiological effects [50,51]. BDNF is a peptide critical for axonal growth, neuronal survival and synaptic plasticity and function. Therefore, it is likely that the consumption of foods containing TFA in their composition could increase the vulnerability to some mental or neurological disorders or act negatively on mental quality of life.

Although our results suggest a detrimental role of TFA on mental quality of life, our findings are modest. The present study was carried out among a sample in which TFA intake was very low (the median of intake was 1 gram per day). This intake was lower than the median intake for Spanish population which is 2.1 grams per day, [52] and far away from the higher consumption corresponded to the United States and Canada with values of 3-4 grams per day [53]. Therefore, the repercussion of these findings might be really important in these populations where the consumption is very high comparing to our cohort and where the main sources of TFA are artificial foods [54].

Several limitations in our study have to be addressed. Diet was ascertained at baseline and quality of life after 4-years of follow-up, therefore we acknowledge that baseline scores of quality of life were unknown. Consequently, in spite of the fact that the follow-up of participants allows a sufficient long induction period, it could still be possible to speculate that a poor-quality diet may be a result of mental health symptoms, rather than a causal factor.

We acknowledge that although the food frequency questionnaire has been validated using dietary records as gold standard, this is not the best method to validate some dietary fatty acids intake such n-3 PUFAs. The use of a validation method with biomarkers as gold standard is recommended. This could lead to certain, probably non-differential, misclassification bias in the dietary n-3 PUFAs assessment.

Another fact to take into account is that quality of life is a complex concept with various dimensions. Nevertheless, the use of the SF-36 questionnaire for evaluating the physical and mental dimensions of quality of life is generally accepted, and its validity and reliability have been demonstrated in many population-based studies [55].

Some strengths of our study also deserve to be mentioned. They include its large sample size, its long-term follow-up, the multiple adjustments of our estimates for a variety of major potential confounders, the existence of published validation studies of our assessments, and the restriction to highly educated participants, which provides a better validity to the self-reported data.

Conclusion

In summary, our findings suggest that TFA is the fat subtype that adversely affects quality of life. This association was stronger for the mental domains than for the physical domains of the SF-36. However, replication of these findings in prospective studies, including also a baseline ascertainment on quality of life scores is required in order to confirm the reported associations and their direction.

List of abbreviations

SUN: Seguimiento Universidad de Navarra; SFA: Saturated fatty acids; PUFA: Polyunsaturated fatty acids; n-3 PUFAs: omega 3 polyunsaturated fatty acids; n-6 PUFAs: omega 6 polyunsaturated fatty acids; TFA: Trans unsaturated fatty acids; MUFA: Monounsaturated fatty acids; CI: Confidence intervals; Q5: 5th quintile; Q1: 1st quintile; OO: Olive oil; CVD: Cardiovascular diseases; BMI: Body mass index; MET: Metabolic Equivalent Time; HRQOL: Health related quality of life; CHD: coronary heart disease; BDNF: Brain derived neurotrophic factor.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

CR and AS-V participated in the planning and conception of the research questions and the study design, contributed on the process of hypothesis generation, data collection, statistical analyses and manuscript preparation. AS-V was the principal investigator of the study and primarily conceptualized the research. CR and PH carried out the data retrieval, statistical analyses, and manuscript drafting. CR drafted the article, and all authors participated in interpreting the data and critically revising the manuscript for important intellectual content. All authors read and approved the final manuscript.

Authors' information

CR is a PhD student at the Department of Clinical Science, University of Las Palmas de Gran Canaria. She is a member of the Nutritional Research group of this university and works as a researcher in the project: "The role of diet and physical activity on quality of life and mental illness in the SUN project". Supported by the Spanish Government (Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias; grant PI080819).

PH is an Associate Professor of Preventive Medicine and Public Health at the Department of Clinical Science, University of Las Palmas de Gran Canaria, Spain. She belongs to the Nutritional Research group of this University.

MB-R is an Associate Professor at the Department of Preventive Medicine and Public Health, University of Navarra, Spain. She is a member of the Scientific Committee of the SUN project.

MR-C is an Associate Professor at the Department of Preventive Medicine and Public Health, University of Navarra, Spain, and also a researcher in the SUN project.

CL is an Assistant Professor at the Department of Preventive Medicine and Public Health, University of Navarra, Spain, and also a researcher in the SUN project.

AS-V is an Associate Professor of Preventive Medicine and Public Health at the Department of Clinical Science, University of Las Palmas de Gran Canaria, Spain. She belongs to the Nutritional Research group of this University and she is the principal researcher of the project: "The role of diet and physical activity on quality of life and mental illness in the SUN project". Supported by the Spanish Government (Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias; grant PI080819).

Contributor Information

Cristina Ruano, Email: cruano@proyinves.ulpgc.es.

Patricia Henriquez, Email: phenriquez@dcc.ulpgc.es.

Maira Bes-Rastrollo, Email: mbes@unav.es.

Miguel Ruiz-Canela, Email: mcanela@unav.es.

Cristina López del Burgo, Email: clopez@unav.es.

Almudena Sánchez-Villegas, Email: asanchez@dcc.ulpgc.es.

Acknowledgements

We are indebted to the participants of the SUN Study for their continued cooperation and participation. We thank to other members of the SUN Group: Alonso A, Ara I, Basterra-Gortari FJ, Benito S, Bes-Rastrollo M, Beunza JJ, Delgado-Rodriguez M, Dierssen T, Doreste J, Guillen-Grima F, Krafka J, Llorca J, Lopez del Burgo C, Marti A, Martinez JA, Nuñez-Cordoba JM, Pimenta AM, Sanchez D, Segui-Gomez M, Serrano-Martínez M, and Vazquez Z.

The SUN Study has received funding from Instituto de Salud Carlos III, Oficial Agency of the Spanish Government for biomedical research (Grants PI01/0619, PI030678, PI040233, PI042241, PI050976, PI070240, PI070312, PI081943, PI080819, PI1002293, PI1002658, RD06/0045, and G03/140), the Navarra Regional Government (36/2001, 43/2002, 41/2005 and 36/2008) and the University of Navarra.

References

  1. Gordon H. Exploration of the value of Health-Related Quality of Life Information from Clinical Research and Into Clinical Practice. Mayo Clin Proc. 2007;82(10):1229–39. doi: 10.4065/82.10.1229. [DOI] [PubMed] [Google Scholar]
  2. Wannamethee G, Shapher AG. Self-assesment of health status and morbidity and mortality in middle-aged British men. Int j epidemiol. 1991;2:239–45. doi: 10.1093/ije/20.1.239. [DOI] [PubMed] [Google Scholar]
  3. World Health Organization (WHO) 2002. Active ageing: A policy Framework. Madrid, Spain; [Google Scholar]
  4. Gutierrez-Bedmar M, Seguí-Gomez M, Gomez-Gracia E, Bes-Rastrollo M, Martínez-González MA. Smoking Status, changes in smoking status and Health-related quality of life: Findings from the SUN ("Seguimiento Universidad de Navarra") Cohort. Int J Environ Res Public Health. 2009;6:310–320. doi: 10.3390/ijerph6010310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Serrano-Aguilar P, Muñoz-Navarro SR, Ramallo-Fariña Y, Trujillo-Martín MM. Obesity and health related quality of life in the general adult population of the Canary Islands. Qual Life Res. 2009;18(2):171–7. doi: 10.1007/s11136-008-9427-1. [DOI] [PubMed] [Google Scholar]
  6. Corica F, Corsonello A, Apolone G. Metabolic syndrome, psychological status and quality of life in obesity: the QUOVADIS Study. Int J Obes. 2008;32(1):185–91. doi: 10.1038/sj.ijo.0803687. [DOI] [PubMed] [Google Scholar]
  7. Pons-Villanueva J, Seguí-Gomez M, Rodríguez de Armenta MJ. Validation of self-reported motor-vehicle crash and related work leave in a multi-purpose prospective cohort. Int J Inj Contr Saf Promot. 2010;12:1–8. doi: 10.1080/17457301003728528. [DOI] [PubMed] [Google Scholar]
  8. Hislop TG, Bajdik CD, Balneaves LG, Holmes A, Chan S, Wu E, Abanto ZU, Butler AL. Physical and emotional health effects and social consequences after participation in a low-fat, high-carbohydrate dietary trial for more than 5 years. J Clin Oncol. 2006;24:2311–2317. doi: 10.1200/JCO.2005.04.3042. [DOI] [PubMed] [Google Scholar]
  9. Plaisted CS, Lin PH, Ard JD, McClure ML, Svetkey LP. The effects of dietary patterns on quality of life: a substudy of the Dietary Approaches to Stop Hypertension trial. J Am Diet Assoc. 1999;99(Suppl 8):S84–S89. doi: 10.1016/s0002-8223(99)00421-6. [DOI] [PubMed] [Google Scholar]
  10. Pisinger C, Toft U, Aadahl M, Glümer C, Jorgensen T. The relationship between lifestyle and self-reported health in a general population: the Inter99 study. Prev Med. 2009;49(5):418–23. doi: 10.1016/j.ypmed.2009.08.011. [DOI] [PubMed] [Google Scholar]
  11. Muñóz MA, Fíto M, Marrugat J, Covas MI, Schröeder H. Adherence to the Mediterranean diet is associated with better mental and physical health. B J Nutr. 2009;101:1821–1827. doi: 10.1017/S0007114508143598. [DOI] [PubMed] [Google Scholar]
  12. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: meta-analysis. BMJ. 2008. pp. 337–1344. [DOI] [PMC free article] [PubMed]
  13. Heidemann C, Schulze MB, Franco OH, van Dam RM, Mantzoros CS, Hu FB. Dietary patterns and risk of mortality from cardiovascular disease, cancer, and all causes in a prospective cohort of women. Circulation. 2008;118(3):230–7. doi: 10.1161/CIRCULATIONAHA.108.771881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Akbaraly TN, Brunner EJ, ferrie JE, Marmot MG, Kivimaki M, Singh-Manoux A. Dietary pattern and depressive symptons in middle age. Br J Psychiatry. 2009;195:408–13. doi: 10.1192/bjp.bp.108.058925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fung TT, Willett WC, Stampfer MJ, Manson JE, Hu FB. Dietary patterns and the risk of CHD in women. Arch Intern Med. 2001;161:1857–62. doi: 10.1001/archinte.161.15.1857. [DOI] [PubMed] [Google Scholar]
  16. Van Dam RM, Rimm EB, Willet WC, Stampfer MJ, Hu FB. Dietary patterns and risk for type 2 DM in U.S. men. Ann Intern Med. 2002;136:201–9. doi: 10.7326/0003-4819-136-3-200202050-00008. [DOI] [PubMed] [Google Scholar]
  17. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2007;7:e1000252. doi: 10.1371/journal.pmed.1000252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fernández-Jarne E, Martı'nez-Losa E, Prado-Santamarı'a M, Brugarolas-Brufau C, Serrano-Martínez M, Martínez-González MA. Risk of first non-fatal myocardialinfarction negatively associated with olive oil consumption: a case-control study in Spain. Int J Epidemiol. 2001;31:474–480. doi: 10.1093/intjepid/31.2.474. [DOI] [PubMed] [Google Scholar]
  19. Kontogianni MD, Panagiotakos DB, Chrysohoou C, Pitsavos C, Zampelas A, Stefanadis C. The impact of olive oil consumption pattern on the risk of acute coronary syndromes: The CARDIO2000 case-control study. Clin Cardiol. 2007;30:125–129. doi: 10.1002/clc.20043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Barzi F, Woodward M, Marfisi RM, Tavazzi L, Valagussa F, Marchioli R. Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial. Eur J Clin Nutr. 2003;57:604–611. doi: 10.1038/sj.ejcn.1601575. [DOI] [PubMed] [Google Scholar]
  21. Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA. 2002;288:2569–2578. doi: 10.1001/jama.288.20.2569. [DOI] [PubMed] [Google Scholar]
  22. Belmaker RH, Agam G. Major depressive disorder. N Engl J Med. 2008;358:55–68. doi: 10.1056/NEJMra073096. [DOI] [PubMed] [Google Scholar]
  23. Martinez-Gonzalez MA, Sanchez-Villegas A, De Irala J, Martí A, Martinez JA. Mediterranean diet and stroke: objectives and design of the SUN project. Seguimiento Universidad de Navarra. Nutr Neurosci. 2002;5:65–73. doi: 10.1080/10284150290007047. [DOI] [PubMed] [Google Scholar]
  24. Seguí-Gomez M, de la Fuente C, Vazquez Z, de Irala J, Martínez-González A. Cohort profile: the 'Seguimiento Universidad de Navarra' (SUN) study. Int J Epidemiol. 2006;35:1417–1422. doi: 10.1093/ije/dyl223. [DOI] [PubMed] [Google Scholar]
  25. Martin-Moreno JM, Boyle P, Gorgojo L, Maisonneuve P, Fernandez-Rodríguez JC, Salvini S, Willet WC. Development and Validation of a Food frequency Questionnaire in Spain. Int J epidemiol. 1993;22:12–9. doi: 10.1093/ije/22.3.512. [DOI] [PubMed] [Google Scholar]
  26. de la Fuente-Arrillaga C, Vázquez Z, Bes-Rastrollo M, Sampson L, Martínez-González MA. Reproducibility of a Food Frequency Questionnaire (FFQ) validated in Spain. Public Health Nutr. 2010;13(9):1364–72. doi: 10.1017/S1368980009993065. [DOI] [PubMed] [Google Scholar]
  27. Fernández-Ballart JD, Piñol JL, Zazpe I, Corella D, Carrasco P, Toledo E, Perez-Bauer M, Martínez-González MA, Salas-Salvadó J, Martín-Moreno JM. Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain. Br J Nutr. 2010;103(12):1808–16. doi: 10.1017/S0007114509993837. [DOI] [PubMed] [Google Scholar]
  28. Mataix Verdú J. Tabla de composición de alimentos españoles. 4. Granada: Universidad de Granada; 2003. [Google Scholar]
  29. Moreiras O, Carbajal A, Cabrera L. Tablas de composición de alimentos. 9. Madrid: Pirámide; 2005. [Google Scholar]
  30. Willet WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65(suppl 4):S1220–1. doi: 10.1093/ajcn/65.4.1220S. [DOI] [PubMed] [Google Scholar]
  31. Kiecolt-Glaser JK, Belury MA, Porter K, Beversdorf DQ, Lemeshow S, Glaser R. Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults. Psychosom Med. 2007;69:217–224. doi: 10.1097/PSY.0b013e3180313a45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ware JE, Snow KK, Kosinski M. SF-36 Health survey: Manual and interpretation guide. Boston, Massachusetts: The Health Institute, New England Medical Center. Boston, MA, USA; 1993. [Google Scholar]
  33. Bes-Rastrollo M, Perez Valdivieso JR, Sanchez-Villegas A, Alonso A, Martinez-Gonzalez MA. Validación del peso e índice de masa corporal auto-declarados de los participantes de una cohorte de graduados universitarios. Rev Esp Obes. 2005;3:183–9. [Google Scholar]
  34. Martinez-Gonzalez MA, López-Fontana C, Varo JJ, Sanchez-Villegas A, Martínez JA. Validation of the Spanish version of the physical activity questionnaire used in the Nurses' health study and the health Professionals' Follow-up study. Public Health Nutr. 2005;8:920–7. doi: 10.1079/phn2005745. [DOI] [PubMed] [Google Scholar]
  35. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O'Brien WL, Basset DR, Schmitz KH, Emplaincourt PO, Jacobs DR Jr, Leon AS. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32(9):S498–504. doi: 10.1097/00005768-200009001-00009. [DOI] [PubMed] [Google Scholar]
  36. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003;348:2599–2608. doi: 10.1056/NEJMoa025039. [DOI] [PubMed] [Google Scholar]
  37. Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics. 1999;15:141–155. doi: 10.2165/00019053-199915020-00003. [DOI] [PubMed] [Google Scholar]
  38. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003;56:395–7. doi: 10.1016/S0895-4356(03)00044-1. [DOI] [PubMed] [Google Scholar]
  39. Stender S, Dyerberg J, Astrup A. High levels of industrially produced trans fat in popular fast foods. N Engl J Med. 2006;354:1650–1652. doi: 10.1056/NEJMc052959. [DOI] [PubMed] [Google Scholar]
  40. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans Fatty Acids and Cardiovascular Disease. N Engl J Med. 2006;354:1601–1613. doi: 10.1056/NEJMra054035. [DOI] [PubMed] [Google Scholar]
  41. Oh K, Hu FB, Manson JE, Stampfer MJ, Willett WC. Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses' health study. Am J Epidemiol. 2005;161:672–679. doi: 10.1093/aje/kwi085. [DOI] [PubMed] [Google Scholar]
  42. Mozaffarian D, Aro A, Willett WC. Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr. 2009;63(Suppl 2):5–21S. doi: 10.1038/sj.ejcn.1602973. [DOI] [PubMed] [Google Scholar]
  43. Uauy R, Aro A, Clarke R, Ghafoorunissa, L'Abbe MR, Mozaffarian D, Skeaff CM, Stender S, Tavella M. WHO Scientific Update on trans fatty acids: summary and conclusions. Eur J Clin Nutr. 2009;63(Suppl 2):68–75S. [Google Scholar]
  44. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J clin Nutr. 2003;77(5):1146–55. doi: 10.1093/ajcn/77.5.1146. [DOI] [PubMed] [Google Scholar]
  45. Ascherio A, Katan MB, Zock PL, Stampfer MJ, Willet WC. Trans fatty acids and coronary heart disease. N Engl J Med. 1999;340(25):1994–8. doi: 10.1056/NEJM199906243402511. [DOI] [PubMed] [Google Scholar]
  46. Wallace SK, Mozaffarian D. Trans fatty acids and non lipid risk factors. Curr Atheroscler Rep. 2009;11(6):423–33. doi: 10.1007/s11883-009-0064-0. [DOI] [PubMed] [Google Scholar]
  47. Morris MC, Evans DA, Tangney CC, Bienas JL, Schneider JA, Wilson RS, Scherr PA. Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Arch Neurol. 2006;63:1085–1088. doi: 10.1001/archneur.63.8.1085. [DOI] [PubMed] [Google Scholar]
  48. Morris MC. The role of nutrition in Alzheimer's disease: epidemiological evidence. Eur J Neurol. 2009;16(Suppl 1):1–7. doi: 10.1111/j.1468-1331.2009.02735.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sanchez-Villegas A, Verberne L, De Irala J, Ruı'z-Canela M, Toledo E, Serra-Majem Ll, Martinez-Gonzalez MA. Dietary Fat Intake and the Risk of Depression: The SUN Project. PLoS ONE. 2011;6(1):e16268. doi: 10.1371/journal.pone.0016268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Anisman H. Cascading effects of stressors and inflammatory immune system activation:implications for major depressive disorders. J Psychiatric Neurosci. 2009;34:4–20. [PMC free article] [PubMed] [Google Scholar]
  51. Karege F, Schwald M, Perroud N, La Harpe R. Neurotrophin levels in post mortem brains of suicide victims ad the effects of anthermorten diagnosis and psychotropic drugs. Brain Res Mol Brain Res. 2005;136:29–37. doi: 10.1016/j.molbrainres.2004.12.020. [DOI] [PubMed] [Google Scholar]
  52. Fernandez San -Juan P-M. Trans fatty acids: sources and intake levels, biological effects and content in commercial Spanish food. Nutr Hosp. 2009;24(5):515–520. [PubMed] [Google Scholar]
  53. Craig-Schmidt MC. Word wide consumption of trans fatty acids. Atheroscler. pp. 1–4. [DOI] [PubMed]
  54. Stender S, Dyerberg J, Astrup A. High levels of industrially produced trans fat in popular fats foods. N Engl J Med. 2006;354:1650–2. doi: 10.1056/NEJMc052959. [DOI] [PubMed] [Google Scholar]
  55. Raczek AE, Ware JE, Bjorner JB, Gandek B, Haley SM, Aaronson NK, Apolone G, Bech P, Brazier JE, Bullinger M, Sullivan M. Overview of the SF-36 health Surrey and the international quality of life assessment (IQOLA) project. J Clin Epidemiol. 1998;51:903–912. doi: 10.1016/S0895-4356(98)00081-X. [DOI] [PubMed] [Google Scholar]

Articles from Nutrition Journal are provided here courtesy of BMC

RESOURCES